home / stock / reph / reph short
Short Information | Recro Pharma Inc. (NASDAQ:REPH)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 259,671 |
Total Actual Volume | 2,366,214 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 12,984 |
Average Short Percentage | 11.20% |
Is there a REPH Short Squeeze or Breakout about to happen?
See the REPH Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-21-2022 | $2.07 | $2.09 | $2.14 | $2 | 141,803 | 12,471 | 8.79% |
03-17-2022 | $2.03 | $2.11 | $2.14 | $2.0273 | 64,550 | 8,431 | 13.06% |
03-16-2022 | $1.97 | $2.04 | $2.07 | $1.97 | 76,747 | 4,896 | 6.38% |
03-15-2022 | $1.96 | $1.98 | $2.015 | $1.94 | 41,685 | 4,352 | 10.44% |
03-11-2022 | $2.1 | $1.98 | $2.125 | $1.93 | 91,248 | 9,174 | 10.05% |
03-09-2022 | $1.85 | $1.9 | $1.93 | $1.84 | 111,849 | 7,777 | 6.95% |
03-08-2022 | $1.72 | $1.83 | $1.88 | $1.71 | 255,477 | 17,733 | 6.94% |
03-07-2022 | $1.76 | $1.7 | $1.81 | $1.68 | 139,374 | 4,079 | 2.93% |
03-04-2022 | $1.75 | $1.75 | $1.79 | $1.67 | 75,140 | 5,811 | 7.73% |
03-03-2022 | $1.78 | $1.76 | $1.8 | $1.72 | 80,746 | 13,099 | 16.22% |
03-02-2022 | $1.72 | $1.78 | $1.81 | $1.695 | 255,368 | 31,874 | 12.48% |
03-01-2022 | $1.67 | $1.68 | $1.72 | $1.66 | 247,577 | 16,630 | 6.72% |
02-23-2022 | $1.52 | $1.55 | $1.58 | $1.52 | 44,180 | 6,062 | 13.72% |
02-22-2022 | $1.58 | $1.55 | $1.61 | $1.54 | 75,632 | 11,507 | 15.21% |
02-17-2022 | $1.7 | $1.67 | $1.75 | $1.65 | 44,204 | 3,151 | 7.13% |
02-16-2022 | $1.6966 | $1.72 | $1.76 | $1.6966 | 26,979 | 1,347 | 4.99% |
02-15-2022 | $1.77 | $1.75 | $1.8 | $1.69 | 73,711 | 15,604 | 21.17% |
02-14-2022 | $1.75 | $1.75 | $1.83 | $1.71 | 101,256 | 13,232 | 13.07% |
02-11-2022 | $1.6678 | $1.71 | $1.76 | $1.66 | 267,977 | 27,462 | 10.25% |
02-10-2022 | $1.7 | $1.69 | $1.75 | $1.67 | 150,711 | 44,979 | 29.84% |
News, Short Squeeze, Breakout and More Instantly...
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATE...
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. ...
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approxi...